Pricing Log in Create free account

Anavex Life Sciences Corp. (AVXL) vs Satellos Bioscience Inc. (MSLE)

Anavex Life Sciences Corp. and Satellos Bioscience Inc. are both Biotechnology companies. Anavex Life Sciences Corp. and Satellos Bioscience Inc. are of similar size ($145.1M and $137.2M). Across the 8 metrics below, Anavex Life Sciences Corp. leads on 5 and Satellos Bioscience Inc. on 3.

Valuation

Metric AVXL MSLE Biotechnology median
P/E n/m n/m 8.42
P/S n/m n/m 10.01
P/B 1.22 2.38 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales n/m n/m 9.41
Earnings yield (10.14%) (28.07%) (31.85%)
Free cash flow yield (21.35%) (20.36%) (24.58%)

Profitability

Metric AVXL MSLE Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (12.80%) (70.45%) (56.36%)
Return on assets (11.70%) (64.76%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVXL MSLE Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (3.85%) 21.20% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVXL MSLE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.62 11.22 4.72
Net debt to EBITDA 2.00 1.05 0.96

Dividend

Metric AVXL MSLE Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric AVXL MSLE Biotechnology median
Market cap 137.19m 145.14m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack